ClearPoint Neuro, Inc. (CLPT) Operating cash flow 2017–2026
ClearPoint Neuro, Inc. (CLPT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$23.9MFY2026 · since FY2017: -$5.8M → -$23.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$23.9M | -167.0% |
| FY2025 | -$8.9M | +34.8% |
| FY2024 | -$13.7M | +15.1% |
| FY2023 | -$16.2M | -27.3% |
| FY2022 | -$12.7M | -62.6% |
| FY2021 | -$7.8M | -173.9% |
| FY2020 | -$2.9M | +38.5% |
| FY2019 | -$4.6M | +22.7% |
| FY2018 | -$6.0M | -3.0% |
| FY2017 | -$5.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CLPT financial trends
CLPT RevenueCLPT Net incomeCLPT Net marginCLPT Gross profitCLPT Gross marginCLPT Operating incomeCLPT Operating marginCLPT Free cash flowCLPT Capital expendituresCLPT Return on equityCLPT Stock buybacksCLPT Dividends paidCLPT Total assetsCLPT Total liabilitiesCLPT Shareholders’ equityCLPT overview →